Climb Bio
CLYM
10.71
+0.03
+0.28%
Climb Bio
US · CLYM
#3610 by market cap
Listed 2021
10.71
+0.03
+0.28%
Live - 5344 symbols - heartbeat 275s ago
· 2026-10-08 09:13
Pre-market
10.50
-1.96%
After-hours
10.71
0.00%
- Market cap
- 615.14M
- P/E (TTM)i
- -13.06
- P/Bi
- 2.57
- EPSi
- -0.88
- Div yieldi
- 0.00%
- 52W posi
- 54%
Reader sentiment
Are you bullish or bearish on CLYM?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 7 years
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 677.00K | 2.43M | 12.35M | 18.92M | 24.86M | 16.03M | 21.17M |
| Research & development | 4.02M | 9.34M | 23.32M | 26.21M | 15.41M | 14.34M | 46.71M |
| Operating profit | -4.70M | -11.77M | -35.67M | -45.14M | -40.28M | -30.36M | -67.88M |
| Pretax profit | -6.55M | -20.67M | -47.48M | -45.24M | -35.12M | -73.90M | -59.85M |
| Tax | -- | -- | -- | -- | -- | -- | -- |
| Net profit | -6.55M | -20.67M | -47.48M | -45.24M | -35.12M | -73.90M | -59.85M |
| Basic EPS | -1 | -2 | -4 | -2 | -1 | -2 | -1 |
| Diluted EPS | -1.08 | -1.97 | -4.24 | -1.72 | -1.30 | -1.53 | -0.88 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 5.69M | 4.10M | 5.82M | 5.56M | 5.84M | 5.65M |
| Research & development | 17.33M | 6.58M | 9.07M | 13.74M | 9.37M | 9.71M |
| Operating profit | -23.02M | -10.68M | -14.89M | -19.30M | -15.21M | -15.36M |
| Pretax profit | -20.78M | -8.67M | -12.89M | -17.52M | -13.72M | -13.50M |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -20.78M | -8.67M | -12.89M | -17.52M | -13.72M | -13.50M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.31 | -0.13 | -0.19 | -0.26 | -0.20 | -0.18 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | 21.28M | 22.00M | 148.25M | 134.39M | 110.26M | 154.87M | 105.85M |
| Cash & ST investments | 21.22M | 20.49M | 136.48M | 123.57M | 106.80M | 150.92M | 101.08M |
| Inventory | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 21.40M | 24.63M | 173.24M | 134.99M | 110.47M | 217.19M | 167.74M |
| Total current liabilities | 783.00K | 3.06M | 6.03M | 6.10M | 2.83M | 4.93M | 6.98M |
| Short-term debt | -- | -- | -- | 300.00K | 334.00K | 157.00K | 256.00K |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 783,000.00 | 3,063,000.00 | 6,038,000.00 | 6,277,000.00 | 2,870,000.00 | 5,306,000.00 | 7,269,000.00 |
| Total equity | 20.61M | 21.57M | 167.20M | 128.72M | 107.60M | 211.88M | 160.48M |
| Retained earnings | -7.47M | -28.14M | -75.62M | -120.86M | -155.98M | -229.88M | -289.73M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 100.28M | 87.38M | 90.96M | 105.85M | 113.40M | 186.64M |
| Cash & ST investments | 98.06M | 84.70M | 86.90M | 101.08M | 109.56M | 183.12M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 200.74M | 192.39M | 182.30M | 167.74M | 152.37M | 246.29M |
| Total current liabilities | 7.04M | 6.21M | 4.95M | 6.98M | 4.07M | 5.93M |
| Short-term debt | 155.00K | 222.00K | 228.00K | 256.00K | 263.00K | 501.00K |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 7,355,000.00 | 6,622,000.00 | 5,301,000.00 | 7,269,000.00 | 4,287,000.00 | 6,747,000.00 |
| Total equity | 193.39M | 185.76M | 177.00M | 160.48M | 148.09M | 239.55M |
| Retained earnings | -250.66M | -259.32M | -272.21M | -289.73M | -303.45M | -316.95M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -5.01M | -14.10M | -36.07M | -37.37M | -20.60M | -15.56M | -54.36M |
| Depreciation & amortization | -- | -- | -- | -- | -- | 0 | 97.00K |
| Free cash flow | -5.01M | -14.10M | -36.07M | -37.37M | -20.60M | -15.56M | -54.54M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 0 | 83.14M | -- | 0 | 119.75M | 0 |
| Ending cash balance | 21.22M | 20.49M | 46.92M | 43.59M | 93.11M | 87.23M | 35.69M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -15.43M | -11.15M | -12.14M | -15.64M | -14.38M | -10.55M |
| Depreciation & amortization | 0 | 38.00K | 29.00K | 30.00K | 38.00K | 33.00K |
| Free cash flow | -15.43M | -11.23M | -12.25M | -15.64M | -14.38M | -10.81M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -- | -- |
| Ending cash balance | 29.02M | 22.68M | 25.80M | 35.69M | 8.36M | 44.25M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -73.17 | -30.58 | -29.72 | -46.26 | -32.15 |
| ROA %i | -34.55 | -99.74 | -52.59 | -29.36 | -28.61 | -45.11 | -31.10 |
| ROIC %i | -- | -- | -73.17 | -30.48 | -33.51 | -51.21 | -36.51 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -42.37 |
| EBIT margin %i | -- | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 27.18 | 7.18 | 24.58 | 22.04 | 38.92 | 31.41 | 15.16 |
| Quick ratioi | 27.10 | 6.69 | 23.71 | 21.33 | 38.57 | 30.61 | 14.47 |
| Debt / assetsi | -- | -- | 0.00 | 0.36 | 0.32 | 0.25 | 0.32 |
| LT debt / equityi | -- | -- | -- | 0.14 | 0.01 | 0.18 | 0.18 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -62.04 | -22.92 | -25.65 | -32.15 | -30.92 | -27.10 |
| ROA %i | -59.97 | -22.35 | -25.09 | -31.10 | -29.90 | -26.27 |
| ROIC %i | -67.93 | -27.66 | -25.60 | -36.51 | -35.24 | -30.36 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 14.25 | 14.08 | 18.38 | 15.16 | 27.86 | 31.45 |
| Quick ratioi | 14.13 | 13.65 | 17.56 | 14.47 | 26.91 | 30.86 |
| Debt / assetsi | 0.24 | 0.33 | 0.32 | 0.32 | 0.31 | 0.53 |
| LT debt / equityi | 0.17 | 0.22 | 0.20 | 0.18 | 0.15 | 0.34 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Quote time 2026-10-08 09:13:14 · For reference only, not investment advice and not tailored to your situation.